Struggling Hologic Adopts Poison Pill After Icahn Claims Stake
Hologic Inc. (HOLX), a maker of cervical cancer and breast biopsy tools, adopted a shareholder’s rights plan after billionaire investor Carl Icahn reported a 13 percent stake in the company and said he may seek board seats.
The rights plan is designed to…
View Post











